Depression in patients with rheumatoid arthritis
: description, causes and mechanisms.
Keywords: Bone mass density, Rheumatoid arthritis
Findings supporting the idea that the onset of autoimmunity may be related to gastrointestinal tract are as follows: (1) microbial composition in subjects with early rheumatoid arthritis
differs to controls, with a reduction of certain bacteria belonging to the family Bifidobacterium and Bacteroides [15, 16], and a marked increase of species belonging to the genus Prevotella .
Many of the delegates who attended are members of the Middle East Rheumatoid Arthritis
Hospital specialists commonly prescribe disease-modifying anti-rheumatic drugs to minimise the chances of rheumatoid arthritis
patients and control groups are found to be different in hypertension (p=0.003) and low HDL (p=0.006) significantly, as hypertension was more common in cases whereas low HDL in controls.
(5) Japan College of Rheumatology, Clinical practice guideline of methotrexate for patients with rheumatoid arthritis
: 2016 update version
To investigate the potential risks and benefits of statins in moderate-risk patients with rheumatoid arthritis
, researchers designed the Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Rheumatoid Arthritis
(TRACE RA), a multi-centre, randomised, double-blind trial comparing the statin atorvastatin with placebo.
Live births per embryo transfer were less likely in women with rheumatoid arthritis
versus those they were in women with no rheumatoid arthritis
, with an adjusted odds ratio of 0.78 (95% confidence interval, 0.65-0.92), according to investigators.
Conclusion: Secondary fibromyalgia is common in patients with rheumatoid arthritis
and needs to be screened out in all patients diagnosed as rheumatoid arthritis
and on subsequent follow up visits, coexisting fibromyalgia affects the disease activity status and this may result into inappropriate and unnecessary changes in treatment plans.
M2 PHARMA-June 19, 2018-AbbVie Releases Positive Outcome Data from Ongoing Upadacitinib Phase 3 Studies in Rheumatoid Arthritis